AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)

Completed · Phase 2 · Has a placebo group

Conditions studied: Anxiety Disorders

In brief

The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.

Key facts

Study ID

NCT00808249

Run by

AstraZeneca

People needed

725

Starts

2008-12-01

Expected to finish

2009-05-01

Last updated by the study team

2011-06-20

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent before any study-related procedures start.
• The patient is previously diagnosed with Generalized Anxiety Disorder.
• The patient has a HADS-A (anxiety) score ≥10 at both screening and randomization.

You may not qualify if…

• Patient has a lifetime history of schizophrenia or other psychotic disorders
• Patient has a history of seizures or seizure disorder.
• Patient is pregnant or breast feeding.
• Patient has received electroconvulsive treatment (ECT) in the past.

Where it is running

• Research Site — Tucson, Arizona, United States
• Research Site — Arcadia, California, United States
• Research Site — Beverly Hills, California, United States
• Research Site — Cerritos, California, United States
• Research Site — Chino, California, United States
• Research Site — Encino, California, United States
• Research Site — Los Alamitos, California, United States
• Research Site — Novato, California, United States
• Research Site — Oceanside, California, United States
• Research Site — San Diego, California, United States
• Research Site — Norwich, Connecticut, United States
• Research Site — Fort Myers, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Pembroke Pines, Florida, United States
• Research Site — Saint Petersberg, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Winter Park, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Marietta, Georgia, United States
• Research Site — Smyrna, Georgia, United States
• Research Site — Libertyville, Illinois, United States
• Research Site — Park Ridge, Illinois, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Overland Park, Kansas, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.